Globally, more than 12 million people are diagnosed with cancer every year. Cancer rates could further increase to 15 million new diagnoses each year by 2020.
Prevention is an important component to any comprehensive cancer control plan. Cancer prevention clinical trials are diverse, multidisciplinary, and designed to lower the incidence of cancer, reduce health disparities, improve quality of life, and identify biomarkers of cancer etiology and risk.
CRAB’s proven expertise in cancer prevention and control include:
- Design, coordination and analysis of cancer prevention studies
- Coordination of meetings and training workshops for investigators and staff
- Rapid recruitment of patients, including minority and medically underserved groups
- Strategies for maintaining excellent patient adherence
- The Selenium and Vitamin E Cancer Prevention Trial (SELECT), with more than 35,000 participants
- An international clinical trial in six Latin American countries to test three different antibiotic regimens to eradicate H. pylori, the principal precursor of stomach cancer. This trial demonstrates our ability to launch and complete trials in rarely studied diseases and locations and our commitment to developing solutions to worldwide health problems
- Centralized, paper- or web-based follow-up for study patients and participants whose clinical trials have ended
- Opportunities for scientists to use the vast biorepository and clinical data to conduct novel translational medicine studies
CRAB is poised to assist clinical investigators with development and implementation of cancer prevention and control studies, and to share strategies for recruitment, adherence and long-term follow-up.